FDA panel to consider Pfizer’s HIV drug maraviroc
The FDA’s antiviral drugs advisory committee will meet April 24 to assess the safety and effectiveness of Pfizer’s first-in-class HIV ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.